2-oxonaphthyridine-3-carboxamides HIV integrase inhibitors
US8691991B2 · kind B2 · utility
2Cited by
0References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 10, 2005 |
| Grant date | Apr 8, 2014 |
| Priority date | — |
| Expiry date | Jun 12, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.